Key Finding
No current non-hormonal alternatives are as effective as estrogen for treating hot flushes, and limited understanding of hot flush mechanisms represents a major obstacle for developing new targeted treatments.
Hot flushes are the most troublesome symptom of menopause, affecting millions of women worldwide. For decades, hormone replacement therapy (HRT) has been the go-to treatment, successfully reducing hot flushes in over 80% of women who use it. However, since major studies like the Women's Health Initiative in the early 2000s raised concerns about potential health risks, many women have become hesitant about taking hormones. In fact, half of all women using HRT in countries like the United States, United Kingdom, and New Zealand stopped their treatment following these reports.
The problem is that when women stop HRT, hot flushes often return with a vengeance. Despite this, only 18% of women choose to restart hormone therapy, with three-quarters of those doing so because their hot flushes or night sweats became unbearable. This leaves a huge number of women searching for alternatives to manage their symptoms without hormones.
Unfortunately, this review found that currently available non-hormonal alternatives are not as effective as estrogen therapy. The authors point out that our limited understanding of exactly why hot flushes happen makes it difficult to develop better targeted treatments. This is where therapies like acupuncture may offer hope, as some women report relief from menopausal symptoms through this approach, though more research is needed to fully understand its effectiveness compared to conventional treatments. If you're considering acupuncture for hot flushes, seek a qualified, licensed practitioner with experience treating menopausal symptoms.
This review examines alternatives to hormone replacement therapy (HRT) for treating hot flushes, the primary indication for HRT prescription. While estrogen demonstrates over 80% efficacy for vasomotor symptoms, post-WHI publications led to 50% of HRT users discontinuing treatment in the UK, USA, and New Zealand. Following discontinuation, only 18% of women resumed HRT, with 76% citing severe recurrent hot flushes or night sweats as the reason. The authors emphasize that current non-hormonal alternatives demonstrate inferior efficacy compared to estrogen therapy. A critical barrier to developing effective targeted treatments is the limited understanding of hot flush aetiology and underlying mechanisms. No specific methodology, sample size, or effect sizes are provided as this is a narrative review rather than an original research study. Clinical takeaway: Practitioners should recognize the significant treatment gap for patients seeking non-hormonal management of vasomotor symptoms, as no current alternatives match estrogen's effectiveness.
Browse our directory of verified licensed practitioners near you.
Find a practitioner โ๐ Dysregulation of m7G RNA modifications, catalyzed by three major methyltransferase complexes in the CNS, is associated with the pathogenesis of multiple neurological diseases including Alzheimer's disease, ALS, epilepsy, glioblastoma, and ischemic stroke.
๐ Acupuncture significantly reduced thyroid antibodies (TPOAb and TGAb) and TSH levels in Hashimoto thyroiditis patients, though methodological limitations prevent reliable clinical recommendations pending higher-quality research.
๐ Liproxstatin-1 significantly reduced cerebral ischemia-reperfusion injury in rats by inhibiting ferroptosis through increasing neuroprotective factors GPX4 and FTH1 while decreasing ferroptosis markers NOX1, ACSL4, COX2, and TFR1.